BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/13/2014 5:50:00 PM | Browse: 815 | Download: 926
Publication Name World Journal of Hepatology
Manuscript ID 12990
Country Japan
Received
2014-07-31 20:52
Peer-Review Started
2014-08-01 20:58
To Make the First Decision
2014-09-16 11:08
Return for Revision
2014-09-27 10:30
Revised
2014-09-30 08:24
Second Decision
2014-10-29 17:47
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-10-29 18:45
Articles in Press
2014-10-29 18:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-12-05 10:16
Publish the Manuscript Online
2014-12-13 17:50
ISSN 1948-5182 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Yoji Kishi, Kazuaki Shimada, Satoshi Nara, Minoru Esaki and Tomoo Kosuge
Funding Agency and Grant Number
Funding Agency Grant Number
Grant-in-aid from the 106th Annual Congress of the JSS Memorial Surgical Research Fund, Tokyo, Japan
Corresponding Author Yoji Kishi, MD, PhD, Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. yokishi@ncc.go.jp
Key Words Hepatocellular carcinoma; Hepatectomy; Repeat hepatectomy; Conversion therapy; Multidisciplinary treatment
Core Tip Previous studies comparing hepatectomy with other nonsurgical treatments for hepatocellular carcinoma (HCC) evaluated which provided superior survival benefit. However, considering the high recurrence rate after curative loco-regional treatment, and limited indications for hepatectomy because of background liver damage, it is important to recognize hepatectomy as a complement to other nonsurgical treatment, rather than a contraindication. A multidisciplinary approach combining and repeating different treatments prolongs patients’ survival with HCC, including those with recurrent or initially unresectable tumors.
Publish Date 2014-12-13 17:50
Citation Kishi Y, Shimada K, Nara S, Esaki M, Kosuge T. Role of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma. World J Hepatol 2014; 6(12): 836-843
URL http://www.wjgnet.com/1948-5182/full/v6/i12/836.htm
DOI http://dx.doi.org/10.4254/wjh.v6.i12.836
Full Article (PDF) WJH-6-836.pdf
Full Article (Word) WJH-6-836.doc
Manuscript File 12990-Review.docx
Answering Reviewers 12990-Answering reviewers.pdf
Copyright License Agreement 12990-Copyright assignment.pdf
Peer-review Report 12990-Peer review(s).pdf
Scientific Misconduct Check 12990-CrossCheck.jpg
Scientific Editor Work List 12990-Scientific editor work list.pdf